LARIAT BIOSCIENCES, INC.

Medtech · Private

Liquid biopsy platform using emulsion digital PCR to detect circulating tumor DNA mutations in blood for cancer diagnostics

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Total capital: $1.0M

Federal grants: $1.0M; 4 awards · 2015–2018; Rank in peer group#460 of 477
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 2; 6 pending · first 2018; Rank in peer group#118 of 477

Capital timeline

Latest events

Sep 2018Federal grantHealth and Human S · Phase I · Comprehensive Liquid Biopsy for Early Stage I/II Screening and Diagnostics of Lung Cancer$210K
Jun 2018Federal grantHealth and Human S · Phase I · Comprehensive Liquid Biopsy for Early Stage I/II Screening and Diagnostics of Lung Cancer$50K
Aug 2017Federal grantHealth and Human S · Phase I · Comprehensive Liquid Biopsy for Early Stage I/II Screening and Diagnostics of Lung Cancer$499K
Apr 2015Federal grantHealth and Human S · Phase I · Liquid Biopsy for Comprehensive Genetic Profiling in Cancer$241K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

Federal grantsBelow median
Granted patents#118 · top 25%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 2 granted of 8

Oct 26, 2021GrantedMicrofluidic DeviceUSPTOUS 11,154,865
Dec 26, 2019PendingCompositions For And Methods Of Enriching Genetic Mutants For Detecting, Diagnosing, And Prognosing CancerUSPTOApplication 16091858
Oct 23, 2018GrantedMicrofluidic Methods For Manipulating DnaUSPTOUS 10,105,702

Show all 8 patent records

Microfluidic DeviceOct 26, 2021 · US 11,154,865Granted
Compositions For And Methods Of Enriching Genetic Mutants For Detecting, Diagnosing, And Prognosing CancerDec 26, 2019 · Application 16091858Pending
Microfluidic Methods For Manipulating DnaOct 23, 2018 · US 10,105,702Granted
Microfluidic DeviceApplication 62383887Pending
Compositions For and Methods of Enriching Genetic Mutants for Detecting, Diagnosing, and Prognosing CancerApplication 62318532Pending
Microfluidic Methods For Manipulating DnaApplication PCTUS2014030346Pending
Microfluidic DeviceApplication PCTUS2017050241Pending
Compositions For And Methods Of Enriching Genetic Mutants For Detecting, Diagnosing, And Prognosing CancerApplication PCTUS2017026110Pending

On Target Laboratories, Inc.Similar federal contract value in Medtech · null in contracts
Harbinger HealthSimilar federal contract value in Medtech · null in contracts
WAVELY DIAGNOSTICS INCSimilar federal contract value in Medtech · null in contracts
APTUS BIOSCIENCES LLCSimilar federal contract value in Medtech · null in contracts
Alaunus BiosciencesSimilar federal contract value in Medtech · null in contracts
AURITEC PHARMACEUTICALS, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.